Introduction. Amiodarone has been used for more than 5 decades for the treatment of
various tachyarrhythmias and previously for the treatment of refractory angina. There are …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Abstract Background and Aims: Hepatotoxic complications of long-term oral amiodarone
therapy have been well described; however, liver injury secondary to parenteral infusion of …

Background Intravenous (IV) amiodarone may be associated with liver injury that may
necessitate drug discontinuation. The prediction of amiodarone induced liver injury (AILI) …

Background Liver cirrhosis is an uncommon but not rare side effect of amiodarone-induced
hepatotoxicity. Patients with hepatitis B virus and hepatitis C virus infections are at a high …

The anti-arrhythmic agent amiodarone (AD) is associated with numerous adverse effects,
but serious liver disease is rare. The improved safety of administration of daily low doses of …

Amiodarone is a widely used and effective long-term antiarrhythmic drug but with known
adverse effects. Prolonged oral administration of this drug has been implicated in numerous …

Objectives Amiodarone is a commonly used anti-arrhythmic drug. Hepatotoxicity following
chronic oral administration occurs in 1% to 3% of patients. Hepatotoxicity following …

Background: Amiodarone is associated with varying degrees of hepatotoxicity. Aims: to
study the association between the presence of the metabolic syndrome or rightsided heart …

Hepatotoxicity caused by chronic oral amiodarone is well documented with around 15-20%
incidence rate. However, acute liver failure due to intravenous (IV) amiodarone is rare …